SWK Holdings Corp $SWKHL

What the company doesAI summary of filing

SWK Holdings Corporation is a specialty finance company that generates income by investing in cash flow streams from life science products through royalty purchases, debt financings, and synthetic revenue interests. The company provides customized financing solutions to biotechnology, pharmaceutical, medical device, and related life science companies, typically focusing on transactions under $50 million where it faces less competition. As of March 2026, the company has executed transactions with 58 parties, funding approximately $876.1 million across the life science sector, earning income through royalties, interest, and fees on its portfolio of debt investments and equity stakes. The company sold substantially all assets of its pharmaceutical development segment in the third quarter of 2025, and now operates solely through its Finance Receivables segment as a revenue-generating business. [10-K 2026-03-20]

Segments: Finance Receivables, Pharmaceutical Development